These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15557051)

  • 1. Botulinum toxin for cerebral palsy; where are we now?
    Morton RE; Hankinson J; Nicholson J
    Arch Dis Child; 2004 Dec; 89(12):1133-7. PubMed ID: 15557051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin A injection for children with spastic cerebral palsy.
    YaJie W; BaoQin G
    Dev Med Child Neurol; 2008 Aug; 50(8):640. PubMed ID: 18754907
    [No Abstract]   [Full Text] [Related]  

  • 3. [Upper extremity botulinum toxin treatment in cerebral palsy. Treatment guidelines the first step towards national cooperation].
    Arner M; Himmelmann K; Pontén E; Stankovic N; Hansson T; Dahlin LB
    Lakartidningen; 2008 Oct 22-28; 105(43):3009-13. PubMed ID: 19024613
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of juvenile spasticity with botulinum toxin type A.
    Desloovere K; Molenaers G
    Nervenarzt; 2008 Jun; 79 Suppl 1():19-21. PubMed ID: 18927960
    [No Abstract]   [Full Text] [Related]  

  • 5. Botulinum toxin type A in the management of cerebral palsy: low or high dose?
    Dai AI
    Pediatr Neurol; 2006 Dec; 35(6):446; author reply 447. PubMed ID: 17138019
    [No Abstract]   [Full Text] [Related]  

  • 6. 'Effectiveness of sedation using nitrous oxide compared with enteral midazolam for botulinum toxin A injections in children'.
    Gubbay A; Langdon K
    Dev Med Child Neurol; 2009 Jun; 51(6):491-2; author reply 492. PubMed ID: 19416317
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the effectiveness of botulinum toxin injections in the lower limb muscles of children with cerebral palsy. Preliminary prospective study of the advantages of ultrasound guidance.
    Py AG; Zein Addeen G; Perrier Y; Carlier RY; Picard A
    Ann Phys Rehabil Med; 2009 Apr; 52(3):215-23. PubMed ID: 19447084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
    Crowner BE; Racette BA
    Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.
    Hu GC; Chuang YC; Liu JP; Chien KL; Chen YM; Chen YF
    Clin Rehabil; 2009 Jan; 23(1):64-71. PubMed ID: 19114438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How do we treat pediatric patients with spastic diplegia?
    Dai AI
    Pediatr Phys Ther; 2006; 18(4):306; author reply 306-7. PubMed ID: 17108805
    [No Abstract]   [Full Text] [Related]  

  • 11. Secondary non-response due to development of neutralising antibodies to botulinum toxin A during treatment of children with cerebral palsy.
    Herrmann J; Mall V; Bigalke H; Geth K; Korinthenberg R; Heinen F
    Neuropediatrics; 2000 Dec; 31(6):333-4. PubMed ID: 11508557
    [No Abstract]   [Full Text] [Related]  

  • 12. Botulinum toxin A in the management of focal muscle overactivity in children with cerebral palsy.
    Gibson N; Graham HK; Love S
    Disabil Rehabil; 2007 Dec; 29(23):1813-22. PubMed ID: 18033606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional outcome of botulinum toxin injection of gastrocnemius and adductors in spastic hemiplegic cerebral palsied children.
    Ibrahim AI; Hawamdeh ZM; Al-Qudah AA
    Eura Medicophys; 2007 Mar; 43(1):13-20. PubMed ID: 17021584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Botulinum neurotoxin A: an unusual systemic effect 43 (2007) 499-501.
    Scheinberg A; O'Flaherty S; Waugh MC; Baxter A; Gurd K
    J Paediatr Child Health; 2008; 44(7-8):468-9; author reply 469. PubMed ID: 18638338
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term effect of botulinum toxin (A) in the management of calf spasticity in children with diplegic cerebral palsy.
    Hawamdeh ZM; Ibrahim AI; Al-Qudah AA
    Eura Medicophys; 2007 Sep; 43(3):311-8. PubMed ID: 17268388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient erectile dysfunction associated with intramuscular injection of botulinum toxin type A.
    Papadonikolakis AS; Vekris MD; Kostas JP; Korompilias AV; Soucacos PN
    J South Orthop Assoc; 2002; 11(2):116-8. PubMed ID: 12741592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of multilevel botulinum toxin a and comprehensive rehabilitation on gait in cerebral palsy.
    Scholtes VA; Dallmeijer AJ; Knol DL; Speth LA; Maathuis CG; Jongerius PH; Becher JG
    Pediatr Neurol; 2007 Jan; 36(1):30-9. PubMed ID: 17162194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
    Kaishou Xu ; Tiebin Yan ; Jianning Mai
    Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of adductor spasticity with BTX-A in children with CP: a randomized, double-blind, placebo-controlled study.
    Mall V; Heinen F; Siebel A; Bertram C; Hafkemeyer U; Wissel J; Berweck S; Haverkamp F; Nass G; Döderlein L; Breitbach-Faller N; Schulte-Mattler W; Korinthenberg R
    Dev Med Child Neurol; 2006 Jan; 48(1):10-3. PubMed ID: 16359588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeat injection of botulinum toxin A is safe and effective for upper limb movement and function in children with cerebral palsy.
    Lowe K; Novak I; Cusick A
    Dev Med Child Neurol; 2007 Nov; 49(11):823-9. PubMed ID: 17979860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.